Business
Why the Orthocell (ASX:OCC) share price is edging higher today
The Orthocell Ltd (ASX: OCC) share price is edging higher today. This comes after the company announced it has completed an important step to obtaining its commercial licence in Australia for its CelGro medical device.
During market open, the Orthocell share price reached as high as 43.5 cents. However, at the time of writing, the company’s shares have slightly retreated to 42.5 cents, up 1.2%.
Quick take on Orthocell
Orthocell focuses on the development and commercialisation of novel collagen medical devices and cellular therapies.
Its lead product, CelGro, facilitates tissue repair and healing in a variety of orthopaedic, reconstructive and surgical applications. This includes treating defects in areas of the body such as…
-
General22 hours agoWallabies vs British and Irish Lions second Test in Melbourne live updates
-
Noosa News22 hours agoLightning halts women’s rugby Test as ‘humdinger’ winter storm lashes Brisbane
-
Noosa News22 hours agoQueensland Premier David Crisafulli throws his support behind controversial beach clubs for the Gold Coast
-
General22 hours agoHong Kong police issue arrest warrants for foreign nationals including Australian citizen Feng Chongyi